ArticleEuropean journal of clinical pharmacology2026
Prescribed drugs and comorbidities as risk factors for Torsades de Pointes arrhythmia: a Swedish population-based cohort study.
Article in European journal of clinical pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Limitations in Assessing Torsades de Pointes Risk in a Swedish Population Based Study : ORCID: [0009-0002-8680-6074].European journal of clinical pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDrug-induced long QT interval syndrome (LQTS) is a risk for Torsade de Pointes (TdP) arrhythmia. The purpose was to investigate patients diagnosed with TdP in relation to dispensed risk drugs, the presence of comorbidities, and sex-differences.
methodsAll patients with a first episode of a registered TdP diagnosis in the National Patient Register between 2006 and 2018 were included in this register-based cohort study. Comorbidities within five years and medications dispensed within 90 days prior to TdP diagnosis were retrieved. Drugs were classified for their risk to cause TdP ("risk drugs") using two different Clinical Decision Support Systems (CredibleMeds and Janusmed).
resultsThe cohort consisted of 762 patients (50% females) with TdP, median age 72 years. A majority (59%) were dispensed at least one risk drug and 338 patients (44%) had at least one risk diagnosis for TdP. Concomitant use of several risk drugs was common. Prior to TdP, 558 patients (73%) had at least one risk diagnosis and/or were dispensed at least one risk drug. More females than males used antidepressants (26% vs 12%, p < 0.01) although the total use of risk drugs were similar in females compared to males. More males than females had risk diagnoses for TdP (53% vs. 36%, p < 0.004).
conclusionA majority of patients with TdP had been dispensed risk drugs and/or had risk diagnoses. Sex-differences in dispensed drugs and risk diagnoses were identified. Prescription drugs, underlying risk diagnoses and sex should be incorporated into the risk assessment for TdP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.